LID & LASH CARE, MADE FOR EVERYDAY LIFE
Cart (0)

For professionals

Care that travels beyond the clinic.

LidHealth is available for in-practice use and patient distribution. Email us for supply and pricing.

lidhealth1@gmail.com

Clinical overview

Meibomian gland dysfunction (MGD)

Meibomian gland dysfunction (MGD) is a common condition affecting the tiny oil-producing glands located in the eyelids. These glands are responsible for secreting oils that form a vital part of the tear film, which helps keep the eyes lubricated and protect them from infections. When these glands become blocked or their secretions become abnormal, it can lead to a range of eye discomfort and other ocular issues. ICD-10 code H02.88 specifically captures cases of Meibomian gland dysfunction of the eyelid, highlighting its significance within ophthalmic health concerns.

ICD-10: H02.88

Causes & symptoms

Common signs and contributing factors

Clinical Causes

  • Blockage of the Meibomian glands due to thickened or altered secretions
  • Inflammation of the eyelids, such as blepharitis
  • Hormonal changes, especially in women during menopause
  • Age-related gland drop-out or degeneration
  • Skin conditions like rosacea
  • Environmental factors like prolonged screen use, exposure to wind or smoke
  • Use of certain cosmetic eyelid products or medications
  • Chronic eyelid hygiene issues

Key Symptoms

  • Oily or greasy-looking eyelid margins
  • Crusty eyelid edges, especially in the mornings
  • Irritation and redness of the eyes
  • A sensation of dryness or grit in the eyes
  • Itching along the eyelid margins
  • Watery eyes or excessive tearing
  • Blurred vision that improves with blinking
  • Sensitivity to light
  • Frequent eyelid inflammation

Assessment

Diagnostic Path

Diagnosis of Meibomian gland dysfunction typically involves a comprehensive eye examination. An ophthalmologist or optometrist will assess the eyelids for signs of gland blockage, inflammation, and abnormal secretions. Special procedures may include expressing the glands to analyze the quality and quantity of the secretions. Additional tests might include eyelid imaging or meibography to visualize gland structure and assess gland loss or atrophy. Patient history regarding symptoms and eyelid hygiene habits will also inform the diagnosis.

Management options

Treatment Protocols

  • Warm compresses applied to eyelids to soften gland secretions and promote drainage
  • Eyelid hygiene with gentle cleaning to reduce inflammation and crusting
  • Massaging the eyelids to express the glands manually
  • Use of artificial tears or lubricating eye drops to relieve dryness
  • Light-based therapies such as intense pulsed light (IPL) to reduce inflammation and gland blockage
  • Topical or oral medications, including antibiotics like doxycycline, for its anti-inflammatory effects
  • Lifestyle modifications, such as reducing screen time and managing environmental exposures
  • In some cases, eyelid scrubs or medications prescribed by an eye care specialist may be recommended for persistent cases

This information is a general clinical overview and does not replace an individual assessment or treatment plan from an eye care professional.